Skip to main content

Table 3 History of lifetime screening, past 12 months screening and HBV vaccination history in the three populations

From: Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study

 

Checkpoint

(n = 2945)

110 Les Halles

(n = 80)

El Pasaje Latino

(n = 72)

N (%)

N (%)

N (%)

HIV screening

 Yes

2632 (89.4)

59 (73.7)

60 (83.3)

 of which rapid tests

889 (33.8)

6 (10.2)

18 (30.0)

 No

248 (8.4)

16 (20.0)

11 (15.3)

 Missing

64 (2.2)

5 (6.2)

1 (1.4)

HIV screening past 12 months

 Yes

1868 (70.9)

29 (49.1)

22 (36.7)

 No

595 (22.6)

28 (47.5)

38 (63.3)

 Missing

170 (6.5)

2 (3.4)

0 (0)

Number of tests past 12 months

 One

1174 (50.0)

27 (87.1)

21 (36.1)

 Two

391 (16.6)

2 (6.4)

28 (48.3)

  ≥ Three

303 (12.9)

0 (0)

9 (15.2)

 Missing

170 (7.2)

1 (3.2)

0 (0)

HBV screening

 Yes

1471 (49.9)

50 (62.5)

48 (66.7)

 No

1029 (34.9)

23 (28.7)

16 (22.2)

 Missing

445 (15.1)

7 (8.7)

8 (11.1)

HBV screening past 12 months

 Yes

726 (49.3)

22 (27.5)

21 (29.1)

 No

410 (27.9)

25 (31.2)

25 (34.7)

 Missing

335 (22.8)

4 (5.0)

2 (2.8)

HCV screening

 Yes

1128 (38.3)

45 (56.2)

35 (48.6)

 No

1096 (37.2)

23 (28.7)

26 (36.1)

 Missing

721 (24.5)

12 (15.0)

11 (15.3)

HCV screening past 12 months

 Yes

610 (54.1)

24 (53.3)

22 (62.9)

 No

273 (24.2)

19 (42.2)

13 (37.1)

 Missing

245 (21.7)

2 (1.9)

0 (0)

HBV vaccination

 Yes, 3 doses

1216 (41.3)

29 (36.2)

26 (36.1)

history

 Not sure

650 (22.1)

14 (17.5)

16 (22.2)

 No

410 (13.9)

27 (33.7)

15 (20.8)

 Missing

668 (22.7)

10 (12.5)

15 (20.8)